DFTX Stock: Insider Activity, Filings & Research
Definium Therapeutics, Inc. (DFTX) — Drillr’s hub for DFTX insider activity, SEC filings, earnings signals and AI research. Over the trailing 3 months, DFTX insiders filed 0 open-market buys and 3 sales (SEC Form 4).
DFTX insider trading activity (SEC Form 4)
Sentiment
0/100
Buys (3m)
0
Sells (3m)
3
Net (3m)
-$797.0K
Context3-month price +32.8%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 26, 2026 | Karlin Danielofficer: Chief Medical Officer | Sell | 8,018 | $18.47 |
| Mar 26, 2026 | Sullivan Markofficer: Chief Legal Officer | Sell | 10,702 | $18.47 |
| Mar 26, 2026 | Barrow Robertdirector, officer: Chief Executive Officer | Sell | 24,431 | $18.47 |
Source: DFTX SEC Form 4 filings, latest Mar 26, 2026. For informational purposes only — not investment advice.
Track DFTX with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free